(1)
Simpson, E.; Kircik, L. .; Blauvelt, A. .; Kuligowski, M.; Venturanza, M.; Sun, K.; Eichenfeld, L. Long-Term Safety and Disease Control With Ruxolitinib Cream in Patients With More Severe Atopic Dermatitis: Pooled Results From Two Phase 3 Studies. J of Skin 2021, 5, s66.